AVXL: Prioritizing core CNS programs and restoring compliance, with a focus on transparency and execution
Regained Nasdaq compliance and addressed internal control weaknesses, with a renewed focus on transparency and disciplined execution. Prioritizing blarcamesine development for Alzheimer's, Rett syndrome, and Fragile X syndrome, while pausing other programs to concentrate resources.Based on Anavex L…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.